These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21666406)

  • 1. Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.
    Harris AD; Johnson JK; Thom KA; Morgan DJ; McGregor JC; Ajao AO; Moore AC; Comer AC; Furuno JP
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):719-22. PubMed ID: 21666406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nosocomial colonization due to imipenem-resistant Pseudomonas aeruginosa epidemiologically linked to breast milk feeding in a neonatal intensive care unit.
    Mammina C; Di Carlo P; Cipolla D; Casuccio A; Tantillo M; Plano MR; Mazzola A; Corsello G
    Acta Pharmacol Sin; 2008 Dec; 29(12):1486-92. PubMed ID: 19026168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections.
    Onguru P; Erbay A; Bodur H; Baran G; Akinci E; Balaban N; Cevik MA
    J Korean Med Sci; 2008 Dec; 23(6):982-7. PubMed ID: 19119440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of patient-to-patient transmission in the acquisition of imipenem-resistant Pseudomonas aeruginosa colonization in the intensive care unit.
    Johnson JK; Smith G; Lee MS; Venezia RA; Stine OC; Nataro JP; Hsiao W; Harris AD
    J Infect Dis; 2009 Sep; 200(6):900-5. PubMed ID: 19673646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical surveillance of surgical imipenem-resistant Pseudomonas aeruginosa infection in a Japanese hospital.
    Sasaki M; Hiyama E; Takesue Y; Kodaira M; Sueda T; Yokoyama T
    J Hosp Infect; 2004 Feb; 56(2):111-8. PubMed ID: 15019222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of intensive care unit relocation and role of tap water on an outbreak of Pseudomonas aeruginosa expressing OprD-mediated resistance to imipenem.
    Tran-Dinh A; Neulier C; Amara M; Nebot N; Troché G; Breton N; Zuber B; Cavelot S; Pangon B; Bedos JP; Merrer J; Grimaldi D
    J Hosp Infect; 2018 Nov; 100(3):e105-e114. PubMed ID: 29857026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
    Zavascki AP; Cruz RP; Goldani LZ
    J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk factors for acquisition of imipenem-resistant Pseudomonas aeruginosa in the burn unit.
    Ozkurt Z; Ertek M; Erol S; Altoparlak U; Akcay MN
    Burns; 2005 Nov; 31(7):870-3. PubMed ID: 15975720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.
    Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
    Infect Control Hosp Epidemiol; 2010 Jan; 31(1):47-53. PubMed ID: 19951202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of emergence of Pseudomonas aeruginosa resistance to beta-lactam antibiotics in intensive care units.
    Georges B; Conil JM; Dubouix A; Archambaud M; Bonnet E; Saivin S; Lauwers-Cancès V; Cristini C; Cougot P; Decun JF; Mathe O; Chabanon G; Marty N; Seguin T; Houin G
    Crit Care Med; 2006 Jun; 34(6):1636-41. PubMed ID: 16557152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor.
    Sorin M; Segal-Maurer S; Mariano N; Urban C; Combest A; Rahal JJ
    Infect Control Hosp Epidemiol; 2001 Jul; 22(7):409-13. PubMed ID: 11583207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial acquisition of Pseudomonas aeruginosa resistant to both ciprofloxacin and imipenem: a risk factor and laboratory analysis.
    Mueller MR; Hayden MK; Fridkin SK; Warren DK; Phillips L; Lolans K; Quinn JP
    Eur J Clin Microbiol Infect Dis; 2008 Jul; 27(7):565-70. PubMed ID: 18299909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit.
    Kohlenberg A; Weitzel-Kage D; van der Linden P; Sohr D; Vögeler S; Kola A; Halle E; Rüden H; Weist K
    J Hosp Infect; 2010 Apr; 74(4):350-7. PubMed ID: 20170982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recovery of imipenem- or ceftazidime-resistant pseudomonas aeruginosa among patients admitted to a teaching hospital in Brazil.
    Fortaleza CM; Freire MP; Filho Dde C; de Carvalho Ramos M
    Infect Control Hosp Epidemiol; 2006 Sep; 27(9):901-6. PubMed ID: 16941313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of conjunctivitis caused by multiresistant Pseudomonas aeruginosa in a Brazilian newborn intensive care unit.
    Brito DV; Oliveira EJ; Matos C; Abdallah VO; Gontijo Filho PP
    Braz J Infect Dis; 2003 Aug; 7(4):234-5. PubMed ID: 14533982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for imipenem-resistant Pseudomonas aeruginosa in neonatal intensive care units in south China.
    Rao YB; Ren ZX; Zhong JJ; Zhong XM; Cao B; Chen DM; Pan XN; Jia YP; Gao PM; Yang BY; Zhong Q; Yang J;
    J Hosp Infect; 2018 Mar; 98(3):305-308. PubMed ID: 29274345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy.
    Eagye KJ; Banevicius MA; Nicolau DP
    Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and molecular epidemiology of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamases from two central hospitals in Portugal.
    Pereira SG; Reis T; Mendez IP; Cardoso O
    Microb Drug Resist; 2013 Oct; 19(5):392-6. PubMed ID: 23758589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Status of nosocomial urinary tract infections in the ICU: molecular epidemiology of imipenem resistant P. aeruginosa].
    Yu SM; Jeon SS; Kang IS; An HG
    Taehan Kanho Hakhoe Chi; 2006 Dec; 36(7):1204-14. PubMed ID: 17211123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.